Trade NAMSW anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
NewAmsterdam Pharma Company N.V. Warrant (NAMSW) is trading at US$16.51, up 0.00% today as of Aug 27, 16:00 EDT. Over the past 52 weeks, NAMSW has traded between US$12.67 and US$30.45. On Syfe you can trade NAMSW with $0 commission and add it to your watchlist.
| Previous close | US$16.51 |
|---|---|
| 52-week range | US$12.67 – US$30.45 |
| Volume | 211 |
| Exchange | US |
Add to Watchlist
Set Price Alert
NewAmsterdam Pharma Company N.V. Warrant
NewAmsterdam Pharma Co. NV is a clinical-stage biopharmaceutical company, which engages in the development of oral, non-statin medicine for patients at high risk of cardiovascular disease with residual elevation of low-density lipoprotein cholesterol. Its lead product candidate, Obicetrapib, is a next-generation, oral, low-dose cholesteryl ester transfer protein inhibitor, which will be used to prevent major adverse cardiovascular events. The company was founded on June 10, 2022 and is headquartered in Naarden, the Netherlands.
Year: 2022
NewAmsterdam Pharma Company N.V. Warrant (NAMSW) stock is trading at US$16.51, 0.00% from the previous close of US$16.51.
The 52-week high for NewAmsterdam Pharma Company N.V. Warrant (NAMSW) stock is US$30.45.
The 52-week low for NewAmsterdam Pharma Company N.V. Warrant (NAMSW) stock is US$12.67.
NewAmsterdam Pharma Company N.V. Warrant (NAMSW) does not currently pay a dividend.
Stay on top of NAMSW
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
